跳至主要内容
临床试验/ISRCTN84527805
ISRCTN84527805已完成未知

Diagnostic accuracy of MRI, diffusion-weighted MRI, FDGPET/CT and Fluoro-ethyl-choline PET/CT in the detection of lymph node metastases in surgically staged endometrial and cervical carcinoma: a non-randomised study

Barts and The London Trust (UK)0 个研究点目标入组 147 人开始时间: 2011年12月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
147

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Females older than 18 years; (no upper limit)
  • 2. Patients with histologically confirmed cancer of the cervix or endometrium
  • 2.1. demonstrated clinically and/or on MRI. In patients with advanced disease being considered for chemoradiotherapy treatment, patients may be considered for entry if paraaortic nodal lymphadenectomy is being used to inform radiotherapy planning
  • 2.2. In patients with endometrial cancer, a) stage 1A with myometrial invasion or any higher stage and grade 3 histology with lymphovascular space invasion, b) stage 1A with myometrial invasion or any other higher stage and serous papillary or clear cell subtypes. The MDT decision may be based on the combination of tumour characteristics on histology, clinical and imaging findings.
  • 3. No contraindication to FDGPET/CT, FECPET/ CT or MRI
  • 4. Fit for surgical lymphadenectomy, as determined by the local MDT. The patient should also be considered fit for extended field radiotherapy in cases where lymphadenectomy is being undertaken to inform radiotherapy planning
  • 5. Able and willing to give written informed consent and to comply with the study protocol procedures; Target Gender: Female ; Lower Age Limit 18 no age limit or unit specified

排除标准

  • 1. Known contraindication to MRI or PET/CT scan
  • 2. Known allergy to FDG or FEC
  • 3. Not considered fit for lymphadenectomy (open or laparoscopic) or, where appropriate, radiotherapy, as determined by the local MDT
  • 4. If the patient is pregnant or breastfeeding
  • 5. Females of childbearing potential must be willing to use an effective method of contraception (hormonal or barrier method of birth control; abstinence) from the time consent is signed until 6 weeks after treatment discontinuation
  • 5. Note: subjects are not considered of childbearing potential if they are surgically sterile (they have undergone bilateral tubal ligation or bilateral oophorectomy) or they are postmenopausal
  • 6. Females of childbearing potential must have a negative pregnancy test prior to being registered for the study
  • 7. Medical or psychiatric illness, which makes the patient unsuitable or unable to give informed consent

研究者

发起方
Barts and The London Trust (UK)

相似试验

Diagnostic accuracy of MRI, diffusion-weighted MRI,... | 临床试验